STOKE THERAPEUTICS INC shareholders Q3 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 23,651$93,1850.00%
UBS Group AG 20,275$79,8840.00%
ALLIANCEBERNSTEIN L.P. 41,320$162,8010.00%
RHUMBLINE ADVISERS 41,009$161,5640.00%
PRINCIPAL FINANCIAL GROUP INC 12,131$47,7960.00%
Squarepoint Ops LLC 15,210$59,9270.00%
BNP PARIBAS FINANCIAL MARKETS 28,152$110,9190.00%
QUADRANT CAPITAL GROUP LLC 221$8710.00%
TWO SIGMA INVESTMENTS, LP 28,300$111,5020.00%
FMR LLC 3,728$14,6880.00%
DIMENSIONAL FUND ADVISORS LP 258,422$1,017,7180.00%
US BANCORP \DE\ 538$2,1200.00%
AMERICAN INTERNATIONAL GROUP, INC. 13,767$54,2420.00%
BANK OF AMERICA CORP /DE/ 57,558$226,7790.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,515$5,9690.00%
WELLS FARGO & COMPANY/MN 6,818$26,8630.00%
NORTHERN TRUST CORP 265,373$1,045,5700.00%
AMERICAN CENTURY COMPANIES INC 16,143$63,6030.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11,916$46,9490.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q3 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.